BET BD2 inhibition facilitates SPOP-mediated degradation of chromatin-associated BRD4/BRD4-NUT, a therapeutic vulnerability in NUT carcinoma
Kathleen Bates, Hoang Nguyen, Kyle P. Eagen, Julianna Huang, Prafulla C. Gokhale, Brittaney A. Leeper, Benjamin K. Eschle, Stacey T Gray, Krupa Sampat, Taylor R Durall, Jia Luo, Geoffrey Ira Shapiro, Steven J. Ferrara, Jacob Gillis, Dustin Rogers, , Christopher Alexander French
The paper shows that selective inhibition of BRD4-BD2 promotes SPOP-mediated degradation of BRD4/BRD4-NUT in NUT carcinoma, leading to better therapeutic outcomes than pan-BET inhibition.
bioRxiv · Aug 19, 2026 · PreprintCancer Biology